Leggat Mccall Realty Investors L P
04/29/2022 | Press release | Archived content
CRISPR Therapeutics Wins ISPE Facility of the Year Award for Innovation
Framingham, MA
4/29/2022
CRISPR Therapeutics has been awarded a 2022 ISPE Facility of the Year Award in the Innovation category for its new cGMP manufacturing facility in Framingham. This 50,000 SF facility has been recognized by ISPE for its unique compact design capable of producing different products at different stages of development, its integration of digital tools into the design, and its innovative approach to building flexibility into the facility. Congratulations to the CRISPR team!
Read more about CRISPR's Framingham award-winning facility and the innovative work the are doing on the ISPE website.
Project Team:
- Owner - CRISPR Therapeutics
- Project Manager - Leggat McCall Properties
- Architect - TRIA Design
- General Contractor/CM - Commodore Builders LLC
Leggat Mccall Realty Investors L P published this content on April 29, 2022, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on April 17, 2026 at 04:34 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]